Morgan Stanley »

Cyclacel Pharmaceuticals shares owned by Morgan Stanley

Quarter-by-quarter ownership of Cyclacel Pharmaceuticals (CYCC) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Cyclacel Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Cyclacel Pharmaceuticals held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cyclacel Pharmaceuticals by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $130 80 1.63
2024-03-31 $169 80 2.11
2023-12-31 $214 80 2.68